Shari LipnerMD, PhD · Nail Division

Dermatology · Nail Division · Weill Cornell Medicine, New York

Nails, examined with academic care.

Dr. Shari Lipner, MD, PhD is a board-certified dermatologist and Director of the Nail Division at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. She sees patients with nail disorders, from dark streaks and nail tumors to fungus, psoriasis and brittle nails.

Line drawing of a fingertip from above, showing the free edge, nail plate, lunula and proximal nail fold, with concentric half-moon arcs radiating from the lunula. 01020 abcd
Fig. 01 The nail unit, seen from above. a Free edge · b Nail plate · c Lunula, the visible part of the matrix where the nail is made · d Proximal nail fold.
Board certificationAmerican Board of Dermatology
Academic rankProfessor of Clinical Dermatology, Weill Cornell Medicine
Peer-reviewed publications700+
EditorialFounding Editor-in-Chief, JAAD Reviews
02Approach

A small structure that signals a great deal.

The nail grows slowly and reacts to many conditions in similar ways. Thickening, color change, lifting and splitting can each have several causes. Getting the diagnosis right comes first, because it decides what treatment makes sense.

Dr. Lipner's clinical work and research focus on exactly that question. She has co-authored expert reviews on evaluating dark nail bands, on confirming nail fungus before treatment, and on managing nail psoriasis. She also leads clinical trials of new nail treatments.

  1. 01HistoryWhen it started, how it has changed, medicines, injuries and family history.
  2. 02ExaminationAll 20 nails, the surrounding skin and, where useful, dermoscopy.
  3. 03TestingNail clippings for fungus, or a nail biopsy when a band or growth needs a definite answer.
  4. 04PlanTreatment options explained with realistic timelines, since nails grow slowly.
03Research

Written for clinicians. Translated for patients.

700+peer-reviewed publications, per her Weill Cornell Medicine profile

Author of the Atlas of Nail Disorders Across All Skin Colors (Springer, 2025) and the Nail Disorders chapter of the Merck Manual Consumer Version.

All selected publications
  1. 2025Evaluation and diagnosis of longitudinal melanonychia: A clinical review by a nail expert group.Ricardo JW, Bellet JS, Jellinek N, et al. J Am Acad Dermatol. PMID 40023404
  2. 2019Onychomycosis: Clinical overview and diagnosis.Lipner SR, Scher RK. J Am Acad Dermatol. PMID 29959961
  3. 2023Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review.Hwang JK, Ricardo JW, Lipner SR. Am J Clin Dermatol. PMID 37209391
  4. 2018Biotin for the treatment of nail disease: what is the evidence?Lipner SR, Scher RK. J Dermatolog Treat. PMID 29057689
Weill Cornell Medicine, New York

Have a nail concern looked at properly.